MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Globus Medical Operating Expenses 2011-2026 | GMED
Annual Operating Expenses Globus Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 547 M | 460 M | 429 M | 377 M | 319 M | 270 M | 251 M | 219 M | 209 M | 197 M | 164 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 547 M | 164 M | 313 M |
Quarterly Operating Expenses Globus Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 320 M | 357 M | 248 M | 149 M | 149 M | - | 129 M | 127 M | 125 M | - | 118 M | 141 M | 118 M | - | 109 M | 124 M | 113 M | - | 109 M | 108 M | 104 M | - | 93.1 M | 93.6 M | 90.8 M | - | 79.2 M | 77.8 M | 79.9 M | - | 66.5 M | 66.8 M | 64.9 M | - | 63.4 M | 64 M | 61 M | - | 55.2 M | 55.4 M | 56.7 M | - | 52.4 M | 71.1 M | 52.3 M | - | 48.8 M | 47 M | 48.3 M | - | 40.6 M | 39.9 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 357 M | 39.9 M | 103 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
614 M | $ 10.89 | -0.11 % | $ 1.63 B |  USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.61 | - | $ 38 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 31.98 | 0.06 % | $ 1.47 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 173.12 | -0.01 % | $ 13 B | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.5 | 2.71 % | $ 1.69 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 282.0 | 1.03 % | $ 7.96 B | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.33 | 0.91 % | $ 125 M |  France |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 37.77 | 0.48 % | $ 5.63 K | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 61.78 | 0.03 % | $ 91.5 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 8.7 | 0.25 % | $ 246 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
40.3 M | $ 24.12 | - | $ 204 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 1.86 | -1.59 % | $ 1.13 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Inogen
INGN
|
184 M | $ 6.34 | 0.16 % | $ 169 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 0.99 | -0.99 % | $ 16.8 M | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.89 | -0.5 % | $ 373 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 62.12 | -1.05 % | $ 3.39 B |  Britain |
 |
LENSAR
LNSR
|
32.6 M | $ 5.59 | -1.93 % | $ 66.8 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 4.13 | 0.61 % | $ 874 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.4 | 3.59 % | $ 373 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.69 | 0.51 % | $ 28.9 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 53.9 | -0.19 % | $ 1.58 B | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 36.26 | -1.31 % | $ 1.13 B | USA |
 |
NanoVibronix
NAOV
|
5.09 M | - | - | $ 1.08 M | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 84.8 | -0.4 % | $ 2.95 B | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.65 | -0.16 % | $ 122 M | USA |